1. Goldstein, J.L.; Hazzard, W.R.; Schrott, H.G.; Biermann, E.L. and Motulsky, A.G.: Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. Journal of Clinical Investigation 52: 1533–1543 (1973).
2. Calvert, G.D.; Graham, J.J.; Mannik, T.; Wise, P.H. and Yeates, R.A.: Effects of therapy on plasma-high-density-lipoprotein cholesterol concentration in diabetes mellitus. The Lancet 2: 66–68 (1968).
3. Ibels, L.S.; Simons, L.A.; King, J.O.; Williams, P.F.; Neale, F.C. and Stewart, J.H.: Studies in the nature and causes of hyperlipidaemia in uraemia, maintenance dialysis and renal transplantation. Quarterly Journal of Medicine 44: 601–614 (1975).
4. Lasser, U.L.; Burns, B. and Solar, S.: Type III hyperlipoproteinemia secondary to hypothyroidism; in Schettler and Weizel (Eds) Atherosclerosis III, p.621–625 (Springer-Verlag, Berlin 1974).
5. Wallace, R.B.; Hoover, J.; Sandler, D.; Rifkind, B.M. and Tyroler, H.A.: Altered plasma lipids associated with oral contraceptive or oestrogen consumption. The Lancet 2: 11–14 (1977).